← All companiesPPalvella Therapeutics, Inc.
PVLA
Palvella Therapeutics, Inc. revenue by year
Palvella Therapeutics, Inc. (PVLA) reported revenue of $42.81M for fiscal year 2023, as filed in its audited annual report with the SEC.
PVLA annual revenue
PVLA revenue 2013-2023
| Fiscal year | Revenue | Change |
|---|
| FY 2023 | $42.81M | +65.3% |
| FY 2022 | $25.90M | -17.6% |
| FY 2021 | $31.42M | +7.1% |
| FY 2020 | $29.32M | -36.6% |
| FY 2019 | $46.28M | +59.0% |
| FY 2018 | $29.10M | +15.1% |
| FY 2017 | $25.27M | +333.5% |
| FY 2016 | $5.83M | +98.9% |
| FY 2015 |
Revenue of similar companies
Frequently asked questions
How has Palvella Therapeutics, Inc.'s revenue changed over time?
Between fiscal 2013 and fiscal 2023, Palvella Therapeutics, Inc.'s revenue grew from $12.43M to $42.81M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.